Letters Rosiglitazone and heart deaths

Glycaemic control is a myth

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39234.451296.3A (Published 14 June 2007) Cite this as: BMJ 2007;334:1236
  1. Illtyd R Thomas, general practitioner
  1. Swansea SA1 5LF
  1. illtyd.thomas{at}gp-w98027.wales.nhs.uk

    Tight control of HbA1c levels has been enshrined in the QOF (quality and outcomes framework) of the new general practitioner contract as being an evidence based proposal. Multiple drugs are licensed on the understanding that they reduce HbA1c levels and that this is a good thing. So should …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe